CD40 promotes MHC class II expression on adipose tissue macrophages and regulates adipose tissue CD4+ T cells with obesity by Morris, David L. et al.
Article
CD40 promotes MHC class II expression on
adipose tissue macrophages and regulates
adipose tissue CD4+ T cells with obesity
David L. Morris,*,1 Kelsie E. Oatmen,† Taleen A. Mergian,† Kae Won Cho,*,2
Jennifer L. DelProposto,* Kanakadurga Singer,* Carmella Evans-Molina,‡ Robert W. O’Rourke,§,{
and Carey N. Lumeng*,3
*Department of Pediatrics and Communicable Diseases, University of Michigan Health System, Ann Arbor, Michigan, USA;
†Literature, Science and Arts Program, University of Michigan, Ann Arbor, Michigan, USA; ‡Department of Medicine, Indiana
University School of Medicine, Indianapolis, Indiana, USA; §Department of Surgery, University of Michigan Medical School, Ann
Arbor, Michigan, USA; {Department of Surgery, Ann Arbor Veteran’s Administration Hospital, Ann Arbor, Michigan, USA
RECEIVED JANUARY 7, 2015; REVISED OCTOBER 30, 2015; ACCEPTED NOVEMBER 4, 2015. DOI: 10.1189/jlb.3A0115-009R
ABSTRACT
Obesity activates both innate and adaptive immune re-
sponses in adipose tissue, but the mechanisms critical for
regulating these responses remain unknown. CD40/CD40L
signaling provides bidirectional costimulatory signals
between antigen-presenting cells and CD4+ T cells, and
CD40L expression is increased in obese humans.
Therefore, we examined the contribution of CD40 to the
progression of obesity-induced inflammation in mice.
CD40 was highly expressed on adipose tissue macro-
phages in mice, and CD40/CD40L signaling promoted
the expression of antigen-presenting cell markers in
adipose tissue macrophages. When fed a high fat diet,
Cd40-deficient mice had reduced accumulation of con-
ventional CD4+ T cells (Tconv: CD3
+CD4+Foxp32) in vis-
ceral fat compared with wild-type mice. By contrast,
the number of regulatory CD4+ T cells (Treg: CD3
+CD4+
Foxp3+) in lean and obese fat was similar between wild-
type and knockout mice. Adipose tissue macrophage
content and inflammatory gene expression in fat did not
differ between obese wild-type and knockout mice;
however, major histocompatibility complex class II and
CD86 expression on adipose tissue macrophages was
reduced in visceral fat from knockout mice. Similar results
were observed in chimeric mice with hematopoietic
Cd40-deficiency. Nonetheless, neither whole body nor
hematopoietic disruption of CD40 ameliorated obesity-
induced insulin resistance in mice. In human adipose
tissue, CD40 expression was positively correlated with
CD80 and CD86 expression in obese patients with type
2 diabetes. These findings indicate that CD40 signaling in
adipose tissue macrophages regulates major histocom-
patibility complex class II and CD86 expression to control
the expansion of CD4+ T cells; however, this is largely
dispensable for the development of obesity-induced in-
flammation and insulin resistance in mice. J. Leukoc. Biol.
99: 1107–1119; 2016.
Introduction
Chronic adipose tissue inflammation has long been implicated
in obesity-associated diseases, such as cardiovascular disease,
type 2 diabetes, and metabolic syndrome. Adipose tissue
inflammation involves activation of both innate and adaptive
immune responses [1, 2]. MHC class II–restricted signals from
macrophages and dendritic cells contribute to T cell activation in
response to obesogenic cues and contribute to metabolic
dysfunction [3–5]. ATMs and dendritic cells can function as
APCs and provide critical cues to generate proinflammatory
signals that include activation of adipose tissue CD4+ T cells
toward a Th1 and effector/memory phenotype [6–8]. Obesity is
also associated with the induction of CD8+ T cells in adipose
tissue and a decrease in Tregs that contribute to a proinflamma-
tory environment [9, 10]. Based on this, there has been
increasing interest in understanding how APC–T cell cross talk
contributes to activation of an adaptive immune response and
adipose tissue inflammation in obesity.
Costimulatory signals from APCs are important for sustaining
T cell activation, and recent studies have aimed to elucidate the
roles of costimulatory molecules in adipose tissue inflammation
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because these may be novel therapeutic targets for mitigating
obesity-induced metabolic inflammation. Costimulatory recep-
tors, such as CD40 and the B7 complex (CD80/CD86), are
induced in adipose tissue of obese humans and animal models
[11–13]. However, the role of these costimulatory molecules in
the development of adipose tissue inflammation and metabolic
dysfunction remains cloudy. Some studies have identified a
beneficial role for costimulation in maintaining a Treg pool, both
systemically and in adipose tissue, which is protective against
obesity-induced inflammation and metabolic disease [5, 13]. In
many other instances, loss of costimulation has been shown to
alter energy use and inflammation in animal models [14–19].
CD40 is a surface glycoprotein, is expressed in hemato-
poietic and nonhematopoietic cells, and is activated by
CD40L/CD154 expressed on T cells and by soluble CD40L
[20, 21]. CD40-CD40L signaling has an important role in
the regulation of APC function and the ability to stimulate
adaptive immunity [22]. In APCs, CD40 activation induces the
expression of MHC II, CD80, and CD86 [23] and enhances
cytokine and chemokine production [24]. Relevant to obesity-
research, serum levels of soluble CD40L are highly correlated
with obesity and metabolic syndrome [25, 26]. Rodent studies
indicate that CD40 deficiency prevents vascular inflammation
and atherosclerosis [17, 27, 28]. Importantly, CD40 deficiency
has been shown to block the proinflammatory M1 activation of
macrophages [28], and CD40 has been identified as a marker of
ATMs in obesity [11].
Several studies have examined the role of CD40 in obesity-
induced inflammation, yet it remains unclear whether CD40/
CD40L signaling has protective or deleterious roles in modulat-
ing adipose tissue inflammation and metabolic homeostasis
[16, 17, 29, 30]. CD40 is expressed on leukocytes and adipose
tissue stromal cells and adipocytes [12, 15, 31], which have
multiple roles in the regulation of adipose tissue metabolism.
CD40 deficiency in T cells potentiated adipose tissue inflamma-
tion during obesity, suggesting a protective function for CD40
signaling [29, 30]. By contrast, a chemical blockade of
CD40-TRAF6 signaling, but not signaling through TRAF2/3/5,
protected mice from obesity-induced insulin resistance and
hepatosteatosis [17, 19]. Obviously, variable results in these
studies may be attributed to differences in the diet used to induce
obesity, to environmental conditions, to differences in gut
microbiota, or to the genetic background strains. Nonetheless, a
consensus for the role of CD40 in obesity-induced adipose tissue
inflammation has not been reached.
Our group is interested in the nature and function of APCs in
adipose tissue, and we have found that ATMs are the primary
functional APC in fat that promote obesity-induced inflammation
[3, 4]. Here, we performed an independent evaluation of the
importance of CD40 in obesity-induced metainflammation to
determine whether CD40/CD0L signaling contributed to
ATM–T cell cross talk in obese adipose tissue. We observed that
Cd402/2 (KO) mice had impaired induction of conventional
CD4+ T cells (Tconv) in adipose tissue with obesity, without any
significant changes in Treg or CD8
+ T cells. This was associated
with a decrease in the expression of MHC class II and CD86
on ATMs in obese KO mice. Bone marrow chimeras generated
from Cd402/2 donors also had reduced Tconv numbers during
dietary obesity. These findings indicate that CD40 signaling
in ATMs regulates MHC II and CD86 expression to control
CD4+ T cell numbers in fat.
MATERIALS AND METHODS
Mice and BMT studies
CD402/2 (B6.129P2-Cd40tm1Kik/J; C57BL/6Ncr background) mice and
congenic C57BL/6J mice (CD45.1 and CD45.2) were purchased from the
Jackson Laboratory (Bar Harbor, ME, USA). Lines were established and
maintained at the University of Michigan (Ann Arbor, Michigan, USA). All
animal procedures complied with the Guide for the Care and Use of Laboratory
Animals from the Institute of Laboratory Animal Research (Washington, DC,
USA), and the University Committee on Use and Care of Animals at the
University of Michigan approved all animal protocols. Beginning at 8 wk of
age, male, WT C57BL/6J and CD402/2 (KO) mice were fed an ND (4.5% fat;
PMI Nutrition International, St. Louis, MO, USA) or an HFD (60% fat;
Research Diets, New Brunswick, NJ, USA) to induce obesity.
BMTs were performed as described [32]. Male recipient WT CD45.1 mice
(8 wk old) were exposed to a single dose of lethal irradiation (900 Rad) 4 h
before receiving 1 3 107 bone marrow cells (i.v.) from either WT (CD45.2) or
KO (CD45.2) male donor mice. Reconstitution was confirmed 6 wk after
transplantation by monitoring CD45.1 (recipient) vs. CD45.2 (donor)
expression on blood leukocytes by flow cytometry. Diet studies were initiated
6 wk posttransfer (14 wk old), and BMT-WT and BMT-KO mice were fed
either ND or HFD for 20 wk.
Isolation of SVCs for immunophenotyping and
cell culture
Adipose tissue SVCs were isolated, as previously described [33]. For cell
culture experiments, SVCs were isolated from epididymal fat pads of male
WT mice fed HFD for 16 wk. SVCs were enriched for CD45+ leukocytes
using mouse CD45 microbeads (Miltenyi Biotec, San Diego, CA, USA)
and plated at 1 3 106 cells/ml in DMEM containing 10% heat-inactivated
FBS. After 3 h, nonadherent cells were removed, and fresh medium was
added. Adherent cells were cultured overnight before being treated
with recombinant mouse CD40 ligand (CD40L; R&D Systems, Minneapolis,
MN, USA) for 6 h.
Flow cytometry analysis
Blood leukocytes were prepared as described [34]. Single-cell suspensions
were prepared from spleen and thymus by pressing tissues through a
40-mm cell strainer (BD Falcon; BD Biosciences, Franklin Lakes, NJ, USA).
SVCs, blood leukocytes, splenocytes, and thymocytes were suspended in
PBS/0.5% BSA (107 cells/ml) and incubated in Fc block (rat anti-mouse
CD16/CD32; eBioscience, San Diego, CA, USA) for 15 min on ice.
Cells were stained with the indicated antibodies for 30 min at 4°C in the
dark. Antibodies used for flow cytometry are provided in Supplemental
Table 1. Foxp3 staining kits (eBioscience) were used according to the
manufacturer’s instructions. Stained cells were washed twice in PBS, fixed in
0.1% paraformaldehyde, and analyzed on a FACSCanto II Flow Cytometer
(BD Biosciences) using FlowJo software (version 9.4; Tree Star, Ashland,
OR, USA).
Isolation of T cells, stimulation, and staining for
CD154 (CD40L)
SVCs were isolated from epididymal fat pads of male WT mice fed an HFD
for 16 wk. SVCs were enriched for CD4+ leukocytes using mouse CD4
microbeads (Miltenyi Biotec) and plated at 1 3 106 cells/ml in RMPI 1640
supplemented with 10% FBS, 10 mM HEPES, 1 mM glutamine, 1 mM sodium
pyruvate, and 50 mm 2-mercaptoethanol. CD4+ splenocytes were also isolated
and treated in parallel as controls. CD4+ T cells were stimulated with PMA
(50 ng/ml) and ionomycin (500 ng/ml) for 2 h and were then treated with
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monensin (2 mM) for an additional 1 h. T cells were collected, fixed, and
permeabilized before staining with CD4 and CD154 antibodies.
Gene expression analysis
Quantitative RT-PCR in mice was performed as described [34]. Adipose
tissue was flash frozen in liquid nitrogen and stored at 280°C until analysis.
Relative gene expression was determined using the 22DDCT method after
normalizing to Arbp expression. Sequences for PCR primers are provided
online (Supplemental Table 2). Gene expression of human adipose tissue was
assessed using TaqMan probes (Applied Biosystems, Foster City, CA, USA).
Metabolic tests
Body weights were measured weekly during experimental periods. Blood
glucose levels (mg/dl) were measured using a glucometer (One Touch Ultra;
Bayer, Whippany, NJ, USA). Mice were fasted for 6 h (10:00 AM–4:00 PM)
before GTTs or ITTs were performed. For GTTs, D-glucose (0.7 g/kg body
weight) was administered (i.p.), and blood glucose levels were measured at
0, 15, 30, 45, 60, 90, and 120 min after injection. For ITTs, human insulin
(1 unit/kg of body weight; Humulin R; Eli Lilly, Indianapolis, IN, USA) was
injected i.p., and blood glucose levels (mg/dl) were measured 0, 15, 30,
45, and 60 min after injection. Plasma insulin levels were measured using an
ultrasensitive mouse insulin ELISA kit (Crystal Chem, Downers Gove, IL,
USA). HOMA-IR values were calculated as fasting insulin (pM/L) 3 fasting
glucose (mM/L)/22.5.
Human adipose tissue samples
Participants (n = 20) were recruited from the University of Michigan Bariatric
Surgery Program (clinical characteristics are provided in Supplemental
Table 3). All participants in this cohort were female. Recruitment and study
protocols were approved by the institutional review board at the University of
Michigan Medical School. Omental adipose tissue biopsies were collected
at the time of surgery, flash frozen, and stored at 280°C before analysis.
Patients with a prior diagnosis of diabetes or taking one or more diabetic
Figure 1. CD40/CD40L expression in visceral
adipose tissue of mice. Male C57BL/6 mice were
fed ND or HFD for 20 wk to induce obesity. (A)
Confocal microscopy images demonstrating CD40
(green) and CD11c (red) expression on ATMs in
eWAT from lean (ND) and obese (HFD) mice.
Staining with rat isotype (IgG2ak) was used as a
control. (B) Representative scatterplots demon-
strating CD40 expression on adipose tissue leuko-
cytes (CD45+) in eWAT from lean mice. (C)
Surface expression of CD40 on ATMs (blue,
CD45+CD11BhighF4/80High), CD11BMidF4/80Mid
SVCs (green), and non-ATMs (red, CD45+
CD11B2F4/802) in eWAT from ND mice. Fluo-
rescence minus one staining (FMO) (2CD40
mAb; shaded) is shown. (D) Histogram showing
CD154 (CD40L) expression levels on unstimu-
lated (2 PMA; black) and stimulated (+ PMA;
red) CD4+ ATTs isolated from eWAT of HFD-fed
mice. Splenocytes were isolated and treated in
parallel as a positive control (lower histogram).
(B–D) The percentage (%; means 6 SEM) of cells
in each gate is indicated.
Morris et al. CD40 regulates adipose tissue T cells
www.jleukbio.org Volume 99, June 2016 Journal of Leukocyte Biology 1109
medications at the time of surgery were considered to be diabetic (n = 9).
Patients were scored for presence or absence of physician-diagnosed
metabolic syndrome criteria for hypertension and hyperlipidemia.
Statistical analysis
Data are presented as means 6 SEM. GraphPad Prism software (version 5.01;
GraphPad Software, La Jolla, CA, USA) was used for statistical analysis.
Differences between groups were determined using unpaired, 2-tailed
Student’s t tests or 1-way ANOVA with Dunnett’s post hoc test. P , 0.05 was
considered significant. The Pearson correlation coefficient was used to
determine the relationship between genes expressed in human adipose tissue
samples.
RESULTS
CD40/CD40L expression in adipose tissue of mice
We have previously shown that Cd40 is expressed in FAC-purified
ATMs and that obesity and inflammatory signals induce Cd40
expression in ATMs [3]. Given the diverse range of cell types
known to express Cd40 in adipose tissue, we used confocal
microscopy and flow cytometry analysis to better delineate the
expression of CD40 protein in situ. By confocal microscopy,
CD40 was detectable on ATMs in the visceral/eWAT from lean
mice fed an ND (Fig. 1A; upper panel). CD40 expression was
detected in both CD11c+ (M1) and CD11c2 (M2) ATMs in obese
fat after feeding HFD for 20 wk (Fig. 1A; middle panel). Low-level
CD40 immunoreactivity was observed on adipocytes by this
method, but signals were significantly lower than on leukocytes,
suggesting that ATMs are the primary cell type expressing CD40
protein in adipose tissue.
We next examined CD40 expression on SVCs in eWAT from lean
mice by flow cytometry. We found that CD40 is expressed almost
exclusively by CD45+ SVCs (Fig. 1B). ATMs (CD45+ CD11BHigh F4/
80High) were identified as the predominant CD40+ leukocyte
population in eWAT, and ;64% of ATMs expressed high levels of
CD40 (Fig. 1C). Approximately 12% of CD45+ CD11BNeg F4/80Neg
SVCs expressed detectable levels of CD40 (Fig. 1C); this compart-
ment contains B and T adipose tissue lymphocytes. A small
percentage (;2%) of CD45+ CD11BMid F4/80Mid SVCs expressed
CD40 (Fig. 1C); these were likely putative adipose tissue dendritic
cells, based on other reports [35]. Collectively, these data indicate
that CD40 expressing ATMs are a major constituent of the stromal
vascular compartment in eWAT from mice.
To support the model that CD40/CD40L signaling contributes
to interactions between ATMs and adipose tissue T cells, we
assessed expression of CD154/CD40L on CD4+ ATT cells. CD154
expression on CD4+ T cells is transient and is detectable only in
activated T cells in many conditions [36–38]. We were unable to
detect CD154 on freshly isolated CD4+ ATTs (data not shown);
however, when we stimulated isolated CD4+ ATTs and spleno-
cytes from HFD-fed mice with PMA/ionomycin ex vivo,
approximately one-half of the CD4+ ATTs expressed CD154 (Fig.
1D). Taken together, these data suggest that CD40/CD40L
signaling molecules may contribute to cross talk between ATMs
and ATTs in adipose tissue.
CD40L signaling induces the expression of APC genes
in ATMs
In mice, alternative splicing of the pre-Cd40 mRNA generates
multiple CD40 isoforms, with and without intact intracellular
domains that convey signaling [34, 39]. Notably, these spliced
variants are not easily distinguishable by the quantitative PCR
strategy that we used to examine Cd40 expression in previous
studies. Therefore, to determine whether CD40 expressed on
ATMs is signaling competently, we treated cultured ATMs with
soluble recombinant mouse CD40L and evaluated the expression
of a number of CD40-regulated genes that are associated with
APC function. CD40L treatment induced robust increases in Il6,
Il12p35, Il12p40, and Tnfa mRNA levels in ATMs from lean mice
(Fig. 2A). The expression of H2-Ab1, the major MHC class II loci
in C57BL/6J mice, as well as costimulatory molecules Cd80 and
Figure 2. CD40L signaling induces the expression
of APC genes in ATMs. SVCs were isolated from
the eWAT of HFD mice and enriched for ATMs
by positive selection (CD45+ microbeads) and
plastic adherence. ATMs were cultured overnight
and then treated with soluble recombinant
mouse CD40L (10 mg/ml) for 6 h. (A–B)
Relative expression of inflammatory and APC
genes in the absence (CON) or presence of
CD40L (n = 4 individual mice/treatment). Data
are means 6 SEM. *P , 0.05, **P , 0.01, ***P ,
0.001.
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Cd86, was also induced by CD40L (Fig. 2B). These findings
indicate that CD40 activation may have a role in potentiating
APC function of ATMs.
CD40 is required from maximal accumulation of
CD4+ ATTs, but not ATMs, in response to
diet-induced obesity
To determine the role that CD40 has in obesity-induced adipose
tissue inflammation, we fed WT and Cd402/2 (KO) mice an
HFD for 20 wk to induce obesity. Both WT and KO mice gained
weight on the HFD, but KO mice gained less weight in
response to HFD compared with WT mice (weight gain: WT, 26.6
6 3.3g; KO, 23.3 6 2.5g; P = 0.03) (Fig. 3A–B). Metabolic
phenotyping did not detect significant differences in energy
expenditure, energy consumption, or locomotor activity that
could explain the differences in body weights between the 2
genotypes on either ND or HFD (data not shown). Despite
this difference in total body weight, HFD KO mice had larger
eWAT depots and smaller livers compared with WT mice
(Fig. 3C–D), suggesting improved efficiency of nutrient storage
in visceral eWAT depots. By contrast, there were no significant
differences in subcutaneous/iWAT in KO and WT mice.
Mean adipocyte size did not differ significantly between KO and
WT mice (Fig. 3E). However, differences in adipocyte size
distribution were noted, with more small adipocytes in the WT
mice and more moderate-sized adipocytes in the KO mice.
We next evaluated whether CD40 has a role in the regulation
of ATTs and ATMs in eWAT during HFD-induced obesity. For
this, we used flow cytometry to identify and quantify ATT and
ATM populations (see Supplemental Fig. 1 for gating strategies).
Data are presented both as the percentage of SVCs and as the
total cell counts normalized to total fat pad weight to account for
the adipose tissue hypertrophy seen in HFD-fed mice. In lean
ND-fed mice, KO mice had an increase in the proportion of total
Figure 3. HFD-induced weight gain, but not visceral adiposity, is reduced in CD40-KO mice. (A) Body weight gain (g) in male WT and KO mice fed
ND or HFD for 18 wk (n = 8–11 mice/group). (B) Body weights in male WT and KO mice after 20 wk of diet exposure (n = 8–11 mice/group). (C)
eWAT, iWAT, and liver weight (g) in WT and KO mice fed ND and HFD for 20 wk (n = 8–11 mice/group). (D) eWAT, iWAT, and liver weight
expressed as a percentage of body weight. (E) Assessment of adipocyte area and size distribution in obese WT and KO mice. Data are means 6 SEM.
*P , 0.05, **P , 0.01, ***P , 0.001. #P , 0.05 vs. ND-fed mice.
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CD3+ lymphocytes in eWAT (Fig. 4A). When normalized to
adipose tissue weight, HFD induced a similar expansion of
total lymphocytes in eWAT in both WT and KO mice. ND-fed
mice had a similar proportion of CD8+ lymphocytes in eWAT, but
KO mice had more CD4+ lymphocytes (Fig. 4B–C). This
difference was lost when normalized to fat mass. HFD exposure
induced similar accumulation of CD8+ lymphocytes in both
genotypes. However, increases in CD4+ ATTs were seen in
HFD-fed WT mice, but not in KO mice. When normalized to fat
mass, HFD-fed KO mice had a significant reduction in the
number of CD4+ ATTs compared with WT mice (Fig. 4C). These
changes in T cells were specific to eWAT because KO and WT
mice had similar numbers of blood (data not shown) and splenic
CD4+ and CD8+ T cells in both diet conditions (Fig. 4F).
We next evaluated the distribution of CD4+ ATTs in
eWAT by assessing Foxp3 expression to differentiate Tconv
(CD3+CD4+Foxp32) and Tregs (CD3
+CD4+Foxp3+) (Fig. 4D). In
ND-fed mice, there were no difference in Tconv, but there was
a significant increase in the number of Tregs in eWAT in the lean
KO mice (Fig. 4E). HFD exposure induced an increase in the
number of Tconvs in eWAT of WT mice, whereas obese KO mice
had significantly fewer Tconvs (Fig. 4E). In contrast, Treg content
in eWAT was comparable in both HFD-fed KO and WT mice
(Fig. 4E). In both diet conditions, the ratio of Tconvs:Tregs in
eWAT was significantly decreased in KO mice (Fig. 4E). Again,
this effect was specific for adipose tissue because KO mice had
slightly more splenic Tconvs and fewer Tregs compared with WT
mice (Fig. 4G). These data suggest that, in lean states, CD40
may serve to limit Treg numbers in adipose tissues. With HFD
exposure, the expansion of a subset of Tconvs in eWAT is dependent
on CD40, which may differ from other secondary lymphoid organs.
We next assessed the influence of CD40 deficiency on ATM
content in eWAT. There were no differences in total ATM
content in eWAT from lean mice between genotypes (Fig. 5A).
With HFD, both WT and KO mice had significant increases in
ATMs, but there was no difference in ATM numbers between
Figure 4. CD40 is required from maximal accumulation of CD4+ ATTs in response to diet-induced obesity. WT and KO mice were fed ND and
HFD, respectively, for 20 wk (n = 5–8 mice/group). ATTs were identified and quantified in eWAT by flow cytometry (see Supplement Fig. 1 for
gating strategy). (A) Quantitation of CD3+ ATTs. Data are expressed as the percentage of total SVCs and total cells/gram of adipose (eWAT) tissue.
(B–C) Quantitation of CD3+CD8+ ATTs, and CD3+CD4+ ATTs. (D) Representative flow plots demonstrating Tconv (Foxp3
2) and Treg (Foxp3
+) CD4+
ATTs in eWAT from WT and KO mice fed an HFD. Percentage of CD4+ ATTs in each gate is indicated. (E) Quantification of Tconv (CD3
+CD4+Foxp32)
and Treg (CD3
+CD4+Foxp3+) ATTs. Ratio of Tconv:Treg ATTs was also determined. (F) Quantification of CD4
+ T cells and CD8+ T cells in spleens from
HFD-fed mice. G: Quantification of Tconv and Treg cells, and ratio of Tconv:Treg in spleens from HFD-fed mice. Data are means 6 SEM. *P , 0.05,
**P , 0.01, ***P , 0.001. #P , 0.05 vs. ND-fed mice.
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obese WT and KO mice. In both WT and KO mice, there was a
similar reduction in the proportion of resident CD206+ ATMs
and an increase in the number of CD11c+ ATMs in eWAT in
response to HFD (Fig. 4B–C).
We assessed the expression levels of genes implicated in
adipose tissue inflammation (Ccl2, Tnfa, Il10, Nos2, Il12p35,
Il12p40, and Ifng). Irrespective of diet, there was no significant
difference in the expression levels of Ccl2, Tnfa, Il12p35, and
Il12p40 between WT and KO mice (Supplemental Fig. 2A–B).
Il10, Nos2, and Ifng expression levels were lower in eWAT from
KO mice fed ND, but the expression of these genes was not
different after HFD (Supplemental Fig. 3A–B). Collectively,
these data indicate that CD40 is required for the maximal
expansion of a pool of CD4+ Tconvs, but not for the recruitment
of CD11c+ ATMs or the regulation of inflammatory genes in
eWAT with HFD-induced obesity.
CD40 regulates MHC class II expression on ATMs
during HFD-induced obesity
MHC class II expression is induced on ATMs in eWAT during
diet-induced obesity [3] and plays a pivotal role in regulating
ATT numbers in mice [4]. Given our observations that CD40L
stimulated H2-Ab1 and Cd86 expression in cultured ATMs
(Fig. 2), we examined the expression of these molecules on
ATMs in HFD-fed obese WT and KO mice. By gene expression
analysis, CD40-deficiency was associated with a modest, but not
statistically significant reduction in H2-Ab1 expression in total
eWAT from lean and obese KO mice (Supplemental Fig. 2C).
Flow cytometry analysis of ATMs from HFD-fed mice revealed
that KO mice had a marked reduction in the frequency of
MHC IIHigh CD86High ATMs and a corresponding increase in the
frequency of MHC IILow CD86Low ATMs compared with WT
mice (Fig. 6A–B). Compared with WT mice, the expression of
MHC II and CD86 expression was also reduced on ATMs from
KO mice (Fig. 6C–D and F–G). No differences in MHC II and
CD86 expression were observed in CD11b+F4/80Low (puta-
tive adipose tissue dendritic cells) or CD11b2F4/802 (non-
ATMs) between obese WT and KO mice. Specific reductions
in MHC II and CD86 expression were observed in both
CD11c+ (recruited M1-like) and CD206+ (resident M2-like)
ATMs (Fig. 6E and H). These findings indicate that CD40 is
required for maximal MHC II and CD86 expression on
ATMs during HFD-induced obesity. This reduction in MHC
II and CD86 expression likely contributes to the impaired
accumulation of Tconv ATTs with diet-induced obesity in KO
mice.
Hematopoietic CD40 promotes MHC class II
expression on ATMs and accumulation of Tconv ATTs
during HFD-induced obesity
Given that CD40 is expressed on multiple cell types, we sought to
evaluate the specific role of Cd40 in hematopoietic cells on
adipose tissue inflammation. BMT experiments were performed
by reconstituting WT recipients with marrow from WT and KO
donors to generate chimeric mice with (BMT-WT) or without
(BMT-KO) CD40 expression on hematopoietic cells. Six weeks
after transplantation, BMT-WT and BMT-KO mice were fed an
ND or an HFD for 20 wk to induce obesity. BMT-WT and
BMT-KO mice had similar leukocyte chimerism in bone marrow,
spleen, eWAT, and blood leukocyte compartments (as a
percentage of their total leukocytes) after reconstitution (Sup-
plemental Fig. 3). BMT-WT and BMT-KO mice did not differ in
weight in both ND- and HFD-fed conditions (Fig. 7A). Obese
BMT-KO and BMT-WT mice had comparable eWAT weight
(Fig. 7B) and similar numbers of ATMs (data not shown). When
we evaluated MHC II expression on ATMs from eWAT, we
observed reduced MHC II expression on ATMs in both ND-
and HFD-fed BMT-KO mice compared with BMT-WT mice
(Fig. 7C). This indicates that CD40 deficiency leads to a
cell-autonomous decrease in MHCII expression in ATMs.
When ATTs were examined, no significant quantitative
differences in total CD3+, CD3+CD8+, or CD3+CD4+ ATTs were
Figure 5. CD40 deficiency does affect ATM infiltration into visceral fat
of mice during diet-induced obesity. WT and KO mice were fed ND
and HFD for 20 wk (n = 8–11 mice/group). ATMs (CD11BHighF4/
80High) were quantified in eWAT by flow cytometry (see Supplement
Fig. 2 for gating strategy). (A) Quantification of ATMs. Data are
expressed as the percentage of total SVCs and total cells/gram of
adipose (eWAT) tissue. (B) Quantification of CD206+ (M2-like) ATMs.
(C) Quantification of CD11c+ (M1-like) ATMs. Data are means 6 SEM.
*P , 0.05. #P , 0.05 vs. ND-fed mice.
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observed between obese BMT-KO and BMT-WT mice (Fig. 7D).
However, Tconv ATTs were significantly reduced in eWAT from
obese BMT-KO mice compared with BMT-WT mice (Fig. 7E). By
contrast, the number of Treg ATTs was comparable between
BMT-KO and BMT-WT mice fed either ND or HFD (Fig. 7E).
The overall ratio of Tconvs:Tregs was reduced in BMT-KO, HFD
mice compared with obese, BMT-WT mice. These observations
with Tconv phenocopy observations in whole-body KO mice and
suggest that hematopoietic CD40 signaling is required for
accumulation of Tconv ATTs with diet-induced obesity.
Whole-body, but not hematopoietic, CD40 deficiency
improves insulin sensitivity during HFD-induced obesity
We evaluated metabolic status of the mice generated in these
experiments by assessing glucose tolerance and insulin sensitivity.
Whole-body obese KO and WT mice had similar impairments
in glucose tolerance and insulin sensitivity as assessed by GTT
and ITT (Fig. 8A–B). However, although HFD-fed KO and WT
mice had similar fasting glucose levels (Fig. 8C), obese KO mice
had lower serum insulin levels and subsequently lower HOMA-IR
scores compared with obese WT controls (Fig. 8D). This is
consistent with an increase of in vivo insulin sensitivity in KO
mice. However, when the bone marrow chimeras were analyzed,
no significant differences in glucose tolerance, insulin tolerance,
fasting glucose or insulin levels, or HOMA-IR were observed
BMT-KO and BMT-WT mice (Fig. 8E–H). These data suggest
that CD40 signaling in nonhematopoietic cells promotes whole-
body insulin resistance.
Coordinated regulation of CD40 and CD80/CD86 gene
expression in omental adipose tissue from obese
diabetic patients
To examine the relevance of CD40 in obese human adipose
tissue, we evaluated CD40, CD80, and CD86 gene expression in
omental adipose tissue biopsies from a cohort of bariatric surgery
patients (n = 20; clinical characteristics in Supplemental Table 3).
There was no significant association with body-mass index and
expression of any of these genes in this population (data not
shown). However, significant correlations were observed between
CD40 and the expression of both CD80 and CD86 in the entire
cohort of obese patients (Fig. 9A–B). The patients were then
subdivided based on the diagnosis of type 2 diabetes (non-
diabetic, n = 11; diabetic n = 9). No significant differences in age
or body-mass index were observed between the nondiabetic and
diabetic groups. There were no differences in absolute expres-
sion of CD40, CD80, and CD86 between diabetic and nondiabetic
groups (data not shown). However, the expression of CD40 and
CD86 was marginally correlated (r = 0.6553; P = 0.0554) in the
diabetic group, and there was a significant positive correlation
(r = 0.8212; P = 0.0066) between CD40 and CD80 expression in
omental fat from obese diabetic patients (Fig. 9C-D). By contrast,
correlation between CD40 and CD80 or CD86 expression did not
reach significance in the nondiabetic group. Thus, the associa-
tion between CD40 and CD80/CD86 expression in omental fat
from this obese cohort is driven primarily by a strong coordinate
regulation of these genes in obese diabetic patients. These
data demonstrate a coordinated regulation of costimulatory
Figure 6. CD40 regulates MHC class II expres-
sion on ATMs during HFD-induced obesity. WT
and KO mice were fed HFD for 20 wk. ATMs
were analyzed by flow cytometry (see Supplement
Fig. 2 for gating strategy). (A) Representative
contour plots showing CD86 and MHC II (MHC
I-A/I-E) expression on ATMs from WT and KO
mice. The percentage (%) of cells in each gate is
indicated. (B) Distribution (% of ATMs) of MHC
IIHigh CD86High, MHC IIHigh CD86Low, MHC
IILow CD86High, and MHC IILow CD86Low ATMs
in eWAT from WT and KO mice fed HFD (n =
5–8 mice/group). (C) Representative histograms
showing surface expression of MHC II (I-A/I-E)
on ATMs from WT (black line) and KO (gray
line) mice fed an HFD. Isotype staining is in-
dicated in the shaded histogram. (D) MHC I-A/I-
E expression (mean fluorescence intensity
[MFI]) on ATMs, CD11BHighF4/80High ATMs,
CD11B+F4/80Low SVCs, and Non-ATMs
(CD11B2F4/802) after HFD exposure (n = 5–8
mice/group). E. Surface expression (MFI) of
MHC I-A/I-E on CD11c+ (M1-like) and CD206+
(M2-like) ATMs from WT and KO mice after
HFD (n = 5–8 mice/group). (F) Representative
histograms showing surface expression of CD86
on ATMs from WT (black line) and KO (gray
line) mice fed an HFD. Isotype staining is indicated
in the shaded histogram. (G) CD86 expression
(MFI) on ATMs, CD11BHighF4/80High ATMs, CD11B+F4/80Low SVCs, and non-ATMs (CD11B2F4/802) after HFD exposure (n = 5–8 mice/group).
(H) Surface expression (MFI) of CD86 on CD11c+ (M1-like) and CD206+ (M2-like) ATMs from WT and KO mice after HFD (n = 5–8 mice/group).
Data are means 6 SEM. *P , 0.05, **P , 0.01.
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genes in obese human adipose tissue, which may be a useful
biomarker for distinguishing metabolically healthy and unhealthy
obese individuals.
DISCUSSION
The emerging concept that activation of the adaptive immune
system links obesity to metabolic disease has led our group and
others to examine the role of leukocyte cross talk in adipose
tissue inflammation [14, 40–43]. T cell costimulation is impor-
tant in APC–T cell communication, and these signals are often
critical nodes in the regulation of both Treg and effector/
memory Tconv activity and homeostasis [18, 44, 45]. Because the
presence or absence of appropriate costimulatory signals likely
influences the magnitude of adipose tissue inflammation in
obesity, many recent studies have examined the role of
costimulatory molecules in this process with somewhat mixed
results. This is likely due to the complexity of costimulatory
receptors and ligands that are expressed on the surface of both
leukocytes and nonleukocytes in adipose tissue. Additionally,
soluble costimulatory molecules, such as CD40L and CD137L, are
increased in obesity and provide another level of costimulatory
regulation [15, 25, 46].
Here, we examined the role of CD40 in the regulation of
adipose tissue inflammation in diet-induced obesity. We found
that Cd402/2 mice have decreased adipose tissue Tconv relative to
Tregs with obesity, which is mainly dependent on CD40
expression in hematopoietic cells. CD40 deficiency was also
associated with reduced MHC II and CD86 expression on both
M1-like (CD11c+) and M2-like (CD206+) ATMs in eWAT
Cd402/2 mice. Because ATMs are the primary APC in adipose
tissue [3, 4], the APC functionality of ATMs is at least partially
dependent on CD40 signaling to generate and maintain of
Tconv in eWAT. Certainly, the reductions in Tconv content in
obese Cd402/2 mice parallels our recent observations that
macrophage-specific deletion of MHCII in mice blunts the
accumulation of Tconv in fat with obesity [4]. Notably, the
increase in Tregs in lean whole-body KO mice was not
recapitulated in BMT-KO mice, suggesting that hematopoietic
and nonhematopoietic CD40 may have divergent effects on
the regulation of Treg content in adipose tissue. Our data are in
line with a report that shows an increase in Tregs in Cd40
2/2
mice [16, 47] but has not been the case in other studies [17,
30]. These findings are also in agreement with the observation
that CD40L deficient mice have increased Tregs and show
protection from insulin resistance with obesity [14]. Nonethe-
less, we observed that these differences are specific to adipose
tissue, which is in line with the unique nature of adipose tissue
Tregs and their unique functional capacity compared with other
induced Treg populations (e.g., spleen) [48, 49].
Figure 7. Hematopoietic CD40 promotes MHC
class II expression on ATMs and accumulation of
Tconv ATTs during HFD-induced obesity. Bone
marrow cells from donor WT or KO mice were
transplanted into lethally irradiated, male, WT
recipients to generate mice with (BMT-WT) or
without (BMT-KO) CD40 expression on hemato-
poietic cells. Both groups were fed an ND or HFD
for 20 wk. (A) Body weight gain in BMT-WT and
BMT-KO mice fed an ND (n = 4 mice/group) or
an HFD (n = 7 mice/group). (B) eWAT weight
(g). (C) MHC I-A/I-E expression (mean fluores-
cence intensity [MFI]) on ATMs from BMT-WT
and BMT-KO mice fed an ND or an HFD for 20
wk. (D) Quantification of CD3+, CD3+CD8+, and
CD3+CD4+ ATTs in eWAT. (E) Quantification of
Tconv and Treg CD3
+CD4+ ATTs and the ratio of
Tconv:Treg ATTs in eWAT. Data are means 6 SEM.
*P , 0.05. #P , 0.05 vs. ND-fed mice.
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Changes in Tconv content have not been observed in other
studies that have mainly focused on CD8+ cells and Tregs. There is
significant variation in how ATT content in adipose tissue is
reported in the literature, which makes it difficult to compare
our results with other studies. Studies report ATT cells as total
cells per adipose tissue fat pad, percentage of adipose tissue
leukocytes, or after normalizing to fat pad weight [16, 17, 30,
47]. This remains a somewhat controversial issue, and there is
no clear, standardized measure of adipose tissue leukocyte
content. For example, we found that HFD-fed Cd402/2 mice
harbor more CD8+ ATTs as a percentage of SVCs, which is in
line with other reports; however, when CD8+ ATT content was
normalized to adipose tissue mass, there was no statistically
significant difference between obese KO and WT mice.
Given the massive expansion in adipose tissue weight with
HFD feeding and the increase in leukocytes within the SVCs,
we feel that some degree of normalization is required. In our
view, reporting ATT cells as a percentage of the all SVCs
and total ATTs per gram adipose tissue are the most
informative for understanding the leukocyte dynamics, so we
present both here.
Despite a reduction in Tconvs, we observed only mild differ-
ences in metabolism based on glucose or insulin sensitivity in
whole-body Cd40 deficient mice and no changes in BM chimeras
made from Cd402/2 donors. Whole-body disruption of Cd40
in C57BL/6 mice offered modest protection from HFD-induced
weight gain and was associated with mild improvement in
insulin sensitivity, as determined by decreased circulating insulin
levels and improved HOMA-IR. This weight difference was
not observed in BM chimeras generated with Cd402/2 donors.
These observations differ from other studies that have shown
both protection and aggravation of insulin resistance in Cd402/2
mice [16, 17, 30]. Different husbandry and diet conditions
among laboratories may contribute to this variation, or it may
relate to studies demonstrating divergent effects of TRAF
signaling pathways downstream of CD40 activation, with
CD40–TRAF6 signaling promoting insulin resistance and CD40
signaling through TRAF2/3/5 having a protective effect on
Figure 8. Whole-body, but not hematopoietic,
CD40 deficiency modestly improves insulin re-
sistance during HFD-induced obesity. (A) Glucose
excursion curve and area under the curve (AUC)
analysis for GTT performed on WT and KO mice
after 15 wk of HFD exposure (n = 8 WT mice; n
= 11 KO mice). (B) Glucose excursion curve for
ITT performed on WT and KO mice after 18 wk
of HFD exposure (n = 8 WT mice; n = 8 KO
mice). (C) Fasting (6 h) blood glucose and
serum insulin levels in WT and KO mice after 19
wk on HFD (n = 8 WT mice; n = 8 KO mice).
(D) HOMA-IR calculated for WT and KO male
mice after 19 wk on HFD. (E) GTT and AUC
analysis for BMT-WT and BMT-KO mice after 15
wk of HFD exposure (n = 7 mice/group). (F)
ITT performed on BMT-WT and BMT-KO mice
after 18 wk of HFD exposure (n = 7 mice/
group). (G) Fasting (6 h) blood glucose and
serum insulin levels in BMT-WT and BMT-KO
mice after 19 wk on HFD (n = 7 mice/group).
(H) HOMA-IR calculated for BMT-WT and BMT-
KO male mice after 19 wk on HFD. Data are
means 6 SEM. *P , 0.05.
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metabolism [17, 19]. Certainly, CD40 expression on non-
hematopoietic cells is an important contributor. The lack of
significant metabolic changes in our obese KO mice parallels
the observation that ATM content, ATM phenotype, and the
expression of inflammatory cytokines were not different when
compared with HFD-fed WT mice. Given that ATMs are potent
effectors of both innate and acquired signals in adipose tissue,
it appears that the activation of ATMs in KO mice may be
largely independent of CD40.
The coregulation of CD40 and costimulatory genes was
recapitulated in human visceral adipose tissue samples, where we
observed positive correlations between CD40 and CD80/CD86
expression in obese patients with type 2 diabetes. This
observation agrees with gene expression profiling studies that
have revealed associations between APC genes and obesity and
metabolic disease in humans [50] and the ability of CD40
receptor activation to induced CD80/86 expression [51]. Few
data exist on the expression of these genes in adipose tissue of
diabetic patients, and cellular analyses have produced mixed
results. CD80+ and CD86+ ATMs were shown to be negatively
associated with insulin resistance in human samples [13]. Others
have reported CD86 expression on ATMs to be an M1 macrophage
marker that does not change significantly with obesity [52]. At the
same time, CD86 is a member of a macrophage-enriched metabolic
network of genes shown to be increased in adipose tissue during
metabolic disease [53–55].
Overall, our studies reveal a novel role for CD40 signaling
in hematopoietic cells. CD40 signaling promotes the
APC functionality of ATMs by controlling MHC II and
CD86 expression. We propose that this has an important
role in translating obesogenic cues into an acquired
immune response associated with the expansion of Tconvs in
adipose tissue. However, in this study, CD40-dependent
generation of Tconvs did not have a significant effect on the
development of insulin resistance, which is likely attributed to
a sustained activation profile for ATMs. This does not
exclude the possible use of inhibitors of the CD40/CD40L
pathway as a possible therapeutic strategy for metabolic
disease but suggests additional pathways to interrogate in the
process.
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